You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch.
You may also report side effects to Genentech at (888) 835-2555.
VENCLEXTA is indicated:
Contraindication
Tumor Lysis Syndrome
Neutropenia
Infections
Immunization
Embryo-Fetal Toxicity
Increased Mortality in Patients with Multiple Myeloma when VENCLEXTA is Added to Bortezomib and Dexamethasone
Adverse Reactions
Drug Interactions
Lactation
Females and Males of Reproductive Potential
Hepatic Impairment
Please see full Prescribing Information.
Venclexta® is the subject of a Collaboration Agreement between AbbVie Inc. and Genentech, Inc.